Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dispenzieri

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.
Leukemia|August 27, 2013
IMWG consensus on risk stratification in multiple myelomaW J Chng, A Dispenzieri, C-S Chim, et al.
Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.
Leukemia|May 8, 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myelomaG Srivastava, V Rana, M Q Lacy, et al.
Bone Marrow Transplantation|June 14, 2019
The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Leukemia|April 6, 2012
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisR L Comenzo, D Reece, G Palladini, et al.
Bone Marrow Transplantation|August 18, 2018
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Leukemia|April 26, 2017
Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myelomaA Dispenzieri, C Tong, B LaPlant, et al.
Leukemia|May 13, 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapyM Alhaj Moustafa, S V Rajkumar, A Dispenzieri, et al.
Blood Cancer Journal|October 22, 2016
Prevalence, incidence and survival of smoldering multiple myeloma in the United StatesA Ravindran, A C Bartley, S J Holton, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|August 3, 2004
Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myelomaS Kumar, M Q Lacy, A Dispenzieri, et al.
Leukemia|August 27, 2013
IMWG consensus on risk stratification in multiple myelomaW J Chng, A Dispenzieri, C-S Chim, et al.
Bone Marrow Transplantation|April 25, 2006
Autologous hematopoietic stem cell transplantation for older patients with relapsed non-Hodgkin's lymphomaF K Buadi, I N Micallef, S M Ansell, et al.
Leukemia|May 8, 2013
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myelomaG Srivastava, V Rana, M Q Lacy, et al.
Bone Marrow Transplantation|June 14, 2019
The impact of re-induction prior to salvage autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Leukemia|April 6, 2012
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisR L Comenzo, D Reece, G Palladini, et al.
Bone Marrow Transplantation|August 18, 2018
Comparable outcomes using propylene glycol-free melphalan for autologous stem cell transplantation in multiple myelomaKevin C Miller, Morie A Gertz, Francis K Buadi, et al.
Leukemia|April 26, 2017
Phase I trial of systemic administration of Edmonston strain of measles virus genetically engineered to express the sodium iodide symporter in patients with recurrent or refractory multiple myelomaA Dispenzieri, C Tong, B LaPlant, et al.
Leukemia|May 13, 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapyM Alhaj Moustafa, S V Rajkumar, A Dispenzieri, et al.
Blood Cancer Journal|October 22, 2016
Prevalence, incidence and survival of smoldering multiple myeloma in the United StatesA Ravindran, A C Bartley, S J Holton, et al.
Pageof 16